A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis. [electronic resource]
Producer: 20020917Description: 160-5 p. digitalISSN:- 0022-202X
- Administration, Topical
- Adolescent
- Adult
- Affinity Labels -- metabolism
- Aged
- Anthralin -- therapeutic use
- Anti-Inflammatory Agents -- therapeutic use
- Azides -- metabolism
- Cyclic AMP -- analogs & derivatives
- Cyclic AMP-Dependent Protein Kinases -- metabolism
- Cyclosporine -- therapeutic use
- Dermatologic Agents -- therapeutic use
- Erythrocyte Membrane -- drug effects
- Etretinate -- therapeutic use
- Female
- Humans
- Keratolytic Agents -- therapeutic use
- Male
- Middle Aged
- Protein Binding -- drug effects
- Psoriasis -- drug therapy
- Retinoids -- therapeutic use
- Severity of Illness Index
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.